Neoantigens, a type of tumor-specific antigens derived from non-silent mutations, are presented by major histocompatibility complex (MHC) molecules and then recognised by T-cell receptors (TCR) as “non-self” peptides. The gene discussed is HLA-C; the disease is neoplasm.